Gottlieb, former director of the US Food and Drug Administration. Image source US "USA Today" website
compiled by Cai Mengyin
According to a report on the "USA Today" website on March 9, the former US Food and Drug Administration (FDA) Gottlieb warned that in the next two weeks, The number of confirmed cases of new coronary pneumonia in the United States may increase sharply.
Gottlieb said that the US federal government should authorize academic institutions and private laboratories to conduct respiratory virus testing earlier. "We have adopted a single-line thinking approach, rather than multi-pronged and flexible processing." He said.
In early February, the Centers for Disease Control and Prevention (CDC) delivered the new coronavirus testing tools developed by the agency to public health laboratories in various states. Due to the failure of the tool, the relevant test results could not be confirmed for a long time, and hospitals and private laboratories in the United States were only allowed to develop and use their own diagnostic methods after a few weeks. The CDC of the United States stated in a statement that as of March 9, 78 public health laboratories in 50 states in the United States have tested the new coronavirus. After the CDC's approval, the laboratories of major academic institutions in the United States, and research institutions such as the American independent medical laboratory LabCorp, have also begun related testing.
"We finally did what we should do, but we are far behind the spread of the virus." Gottlieb said, "Maybe before we realize it, the epidemic has already broken out in some major cities in the United States. In the next two weeks, the number of confirmed cases of new coronary pneumonia in the United States may increase sharply."
editor Jia Xiaojing
This article is from the client of China Youth Daily. To read more exciting information, please download the China Youth Daily client (http://app.cyol.com)
Source: China Youth Daily client
